	Bruttoergebnis Vom Umsatz		Datum
Acadia Pharmaceuticals	USD 256.99M	13.15M	2025-09
Akebia Therapeutics	USD 49.21M	13.25M	2025-03
ALKERMES	USD 265.83M	8.06M	2025-09
Alnylam Pharmaceuticals	USD 829.31M	219.56M	2025-12
Amarin	USD 22.21M	28.15M	2025-09
ANI Pharmaceuticals	USD 111.79M	1.68M	2025-09
BioMarin Pharmaceutical	USD 631.2M	39.27M	2025-09
Coherus Biosciences	USD 4.95M	15.34M	2025-03
Exact Sciences	USD 583.93M	21.48M	2025-09
Exelixis	USD 572.18M	7M	2025-12
Glaxosmithkline	GBP 8.75B	2.92B	2025-09
Heron Therapeutics	USD 23.35M	1.6M	2024-09
Ionis Pharmaceuticals	USD 155M	293M	2025-09
Ironwood Pharmaceuticals	USD 85.24M	44.1M	2025-06
Lexicon Pharmaceuticals	USD -16.16M	2.89M	2024-06
Lonza	CHF 1.29B	248M	2025-06
Merck	USD 13.42B	431M	2025-09
Moderna	USD 226M	583M	2025-12
Myriad Genetics	USD 143.8M	8M	2025-09
Nektar Therapeutics	USD 13.75M	650K	2024-06
Neurocrine Biosciences	USD 787.9M	7M	2025-12
Pacira	USD 130.92M	5M	2025-09
Pfizer	USD 3.54B	7.61B	2025-09
PTC Therapeutics	USD 187.69M	24.3M	2025-09
Sanofi	EUR 8.45B	1.31B	2025-12
Sarepta Therapeutics	USD 247.9M	209.96M	2025-09
United Therapeutics	USD 602.1M	108.9M	2025-09
Vanda Pharmaceuticals	USD 50.6M	5.5M	2024-12
Xoma	992K	846K	2024-06

Emergent BioSolutions Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.